Skip to main content
Fig. 1 | Basic and Clinical Andrology

Fig. 1

From: Clinical endocrinological evaluation of the gonadal axis (testosterone, LH and FSH) in prostate cancer patients switched from a GnRH antagonist to a LHRH agonist

Fig. 1

Serum testosterone levels (LC-MS/MS) of the study patients at various time points. After the administration of leuprolide, a testosterone surge of up to 50 ng/dl was observed in same three cases (63 ng/dl: No.30 in the 1 m group, 80 ng/dl: No.18 in the 2 m group, and 142 ng/dl: No.10 in the 3 m group). “surge (-) total (n = 33)” shows mean of serum testosterone in 33 patients who has no testosterone surge of up to 50 ng/dl. Error bar shows S.D

Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190